These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 14973102)
1. BRCA1 and BRCA2 mutations in women from Shanghai China. Suter NM; Ray RM; Hu YW; Lin MG; Porter P; Gao DL; Zaucha RE; Iwasaki LM; Sabacan LP; Langlois MC; Thomas DB; Ostrander EA Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):181-9. PubMed ID: 14973102 [TBL] [Abstract][Full Text] [Related]
2. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160 [TBL] [Abstract][Full Text] [Related]
3. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Li WF; Hu Z; Rao NY; Song CG; Zhang B; Cao MZ; Su FX; Wang YS; He PQ; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Liu XY; Zhou J; Wang L; Zhao L; Liu YB; Yuan WT; Yang L; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763 [TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. Pietschmann A; Mehdipour P; Mehdipour P; Atri M; Hofmann W; Hosseini-Asl SS; Scherneck S; Mundlos S; Peters H J Cancer Res Clin Oncol; 2005 Aug; 131(8):552-8. PubMed ID: 15918047 [TBL] [Abstract][Full Text] [Related]
8. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766 [TBL] [Abstract][Full Text] [Related]
9. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Malone KE; Daling JR; Neal C; Suter NM; O'Brien C; Cushing-Haugen K; Jonasdottir TJ; Thompson JD; Ostrander EA Cancer; 2000 Mar; 88(6):1393-402. PubMed ID: 10717622 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients. Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436 [TBL] [Abstract][Full Text] [Related]
12. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767 [TBL] [Abstract][Full Text] [Related]
13. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Mann GJ; Thorne H; Balleine RL; Butow PN; Clarke CL; Edkins E; Evans GM; Fereday S; Haan E; Gattas M; Giles GG; Goldblatt J; Hopper JL; Kirk J; Leary JA; Lindeman G; Niedermayr E; Phillips KA; Picken S; Pupo GM; Saunders C; Scott CL; Spurdle AB; Suthers G; Tucker K; Chenevix-Trench G; Breast Cancer Res; 2006; 8(1):R12. PubMed ID: 16507150 [TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077 [TBL] [Abstract][Full Text] [Related]
15. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716 [TBL] [Abstract][Full Text] [Related]
16. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada]. Tonin PN Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312 [TBL] [Abstract][Full Text] [Related]
18. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2. Frank TS; Deffenbaugh AM; Hulick M; Gumpper K Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259 [TBL] [Abstract][Full Text] [Related]
19. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778 [TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. Bergthorsson JT; Ejlertsen B; Olsen JH; Borg A; Nielsen KV; Barkardottir RB; Klausen S; Mouridsen HT; Winther K; Fenger K; Niebuhr A; Harboe TL; Niebuhr E J Med Genet; 2001 Jun; 38(6):361-8. PubMed ID: 11389159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]